Dhampur Bio Organics Ltd (DBOL) AI Stock Analysis

Dhampur Bio Organics Ltd

(NSE:DBOL)

Select Model

Rating:69Neutral

Price Target:INR 128.00▲(4.26% Upside)

Action:downgraded

Date:10/07/26

The overall stock score of 69 reflects a balance between strong bullish momentum and an attractive valuation, offset by notable underlying fundamental weaknesses. The most impactful strengths are the stock's cheap P/E ratio of 9.81 and its robust technical uptrend above all major moving averages. However, long-term upside is constrained by severe profitability concerns, specifically deteriorating margins and a significantly weakened return on equity. The stock currently acts as a strong value and momentum play, but sustainable growth will require translating resilient revenues and cash flows into true bottom-line profitability.

Positive Factors

Revenue GrowthThe reported 10.24% revenue growth indicates renewed top-line expansion, which can support better utilization of the company’s processing base and provide a broader revenue foundation. If sustained, growth would improve operating leverage and help rebuild earnings capacity over the next several quarters.

Negative Factors

Margin CompressionThe sharp reduction in net and gross margins leaves less profit from each unit of revenue and reduces the company’s ability to absorb operating or commodity-cost pressure. Persistently thin margins could constrain reinvestment, weaken earnings resilience and limit returns even if revenue grows.

Dhampur Bio Organics Ltd (DBOL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 8.21B
Dividend Yield: 1.22%
Average Volume (3M): 21.01K
Price to Earnings (P/E): 9.6
Beta (1Y): 0.85
Revenue Growth: 10.24%
EPS Growth: ―
Country: India
Employees: 1,692
Sector: General
Sector Strength: 55
Industry: Agricultural Farm Products

Dhampur Bio Organics Ltd Business Overview & Revenue Model

Company Description

Dhampur Bio Organics Ltd., founded in 2020 and headquartered in New Delhi, India, functions as a holistic sugarcane processing enterprise. The company's operations in India involve the manufacturing and distribution of various products, such as refin...

How the Company Makes Money

DBOL makes money primarily by selling products derived from sugarcane processing through multiple revenue streams: (1) Sugar sales: The core revenue stream comes from manufacturing sugar and selling it to institutional buyers (such as wholesalers, in...

Dhampur Bio Organics Ltd Financial Statement Overview

Summary

Financial performance is mixed. While the company boasts strong recent free cash flow generation (1.14 billion) and manageable debt levels, it faces severe structural profitability headwinds. Shrinking net profit margins (1.19%) and a plummeted return on equity (2.45%) highlight significant operational inefficiencies and challenges in cost control.

Income Statement

42Neutral

Balance Sheet

52Neutral

Cash Flow

68Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	21.17B	21.09B	18.62B	18.39B	24.08B	15.54B
Gross Profit	4.40B	3.39B	4.76B	3.65B	5.50B	2.20B
EBITDA	1.70B	1.63B	1.38B	1.59B	2.13B	1.90B
Net Income	839.70M	251.80M	146.90M	464.90M	1.11B	1.02B
Balance Sheet
Total Assets	0	23.22B	23.98B	23.13B	20.77B	20.01B
Cash, Cash Equivalents and Short-Term Investments	87.10M	361.60M	389.80M	293.90M	1.04B	229.80M
Total Debt	0	10.60B	11.62B	10.57B	8.10B	8.35B
Total Liabilities	-10.27B	12.95B	13.86B	13.01B	10.89B	11.23B
Stockholders Equity	10.27B	10.27B	10.12B	10.11B	9.89B	8.77B
Cash Flow
Free Cash Flow	6.69B	1.15B	-161.70M	-2.72B	1.45B	-4.08B
Operating Cash Flow	6.89B	1.59B	1.30B	-1.01B	3.55B	-2.46B
Investing Cash Flow	-178.20M	-422.00M	-1.46B	-1.66B	-1.96B	-1.38B
Financing Cash Flow	-6.52B	-1.17B	187.90M	1.70B	-781.20M	3.94B

Dhampur Bio Organics Ltd Technical Analysis

Technical Analysis SentimentNeutral

Last Price122.77

Price Trends

50DMA127.05Negative

100DMA118.82Positive

200DMA110.86Positive

Market Momentum

MACD-1.30Positive

RSI44.33Neutral

STOCH16.37Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DBOL, the sentiment is Neutral. The current price of 122.77 is below the 20-day moving average (MA) of 133.27, below the 50-day MA of 127.05, and above the 200-day MA of 110.86, indicating a neutral trend. The MACD of -1.30 indicates Positive momentum. The RSI at 44.33 is Neutral, neither overbought nor oversold. The STOCH value of 16.37 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:DBOL.

Dhampur Bio Organics Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:DBOL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:GODREJAGRO	72Outperform	INR 106.57B	24.02	―	1.97%	8.58%	-1.86%
IN:KMSUGAR	71Outperform	INR 2.85B	6.09	―	―	-8.26%	15.48%
IN:DBOL	69Neutral	INR 7.79B	9.64	―	1.22%	10.24%	―
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:SAKHTISUG	46Neutral	INR 1.92B	7.12	―	―	16.25%	30.67%
IN:KOTARISUG	45Neutral	INR 1.86B	33.94	―	―	-8.21%	-55.42%
IN:RENUKA	40Underperform	INR 36.93B	-4.84	―	―	-9.87%	18.65%

* General Sector Average

Performance Comparison

IN:DBOL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:DBOL	Dhampur Bio Organics Ltd	122.55	44.28	56.57%
IN:GODREJAGRO	Godrej Agrovet Limited	557.25	-79.67	-12.51%
IN:KMSUGAR	K.M. Sugar Mills Ltd.	31.89	9.77	44.17%
IN:KOTARISUG	Kothari Sugars & Chemicals Ltd.	22.40	-8.18	-26.75%
IN:RENUKA	Shree Renuka Sugars Limited	17.72	-11.52	-39.40%
IN:SAKHTISUG	Sakthi Sugars Limited	16.26	-4.14	-20.29%

Dhampur Bio Organics Ltd Corporate Events

Dhampur Bio Organics Announces Resignation of VP Financial Planning and Analysis

Oct 31, 2026

Dhampur Bio Organics Ltd. has announced the resignation of Harmeet Singh from his role as Vice President – Financial Planning and Analysis, following a letter submitted on October 9, 2026. His cessation from the position will be effective at th...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 06, 2026

Dhampur Bio Organics Ltd AI Stock Analysis